hospital patient News
-
FB2001 (Bofutrelvir) Phase II/III Clinical Trial Protocol Approved by NMPA
Frontier Biotech (stock code: 688221.SH) announced that the Phase II/III clinical study protocol of FB2001 (generic name: Bofutrelvir) is approved by the Center for Drug Evaluation, NMPA. The study is a worldwide multi-center, randomized, double-blind and placebo-controlled Phase II/III trial to evaluate the safety and efficacy of Bufutrelvir for hospitalized Covid-19 patients. Frontier Biotech ...
-
MFDS Greenlights VUNO Med-DeepCARS, AI Medical Device for Cardiac Arrest Prediction
South Korean artificial intelligence (AI) developer, VUNO Inc. announced today that it has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) for its VUNO Med®–DeepCARS™, an AI medical device for cardiac arrest prediction through vital signs. VUNO Med®–DeepCARS™ is a breakthrough AI-driven medical device that analyzes the potential risk ...
By Vuno Inc.
-
An Investigator Initiated Clinical Trial of Inhaled Bofutrelvir for Post-Exposure Prophylaxis in Close Contacts of COVID-19 Patients
Shanghai Ruijin Hospital recently announced that it has initiated an investigator-initiated clinical trial (IIT) to evaluate the safety and efficacy of Bofutrelvir administered by inhalation for post-exposure prophylaxis in close contacts of COVID-19 (NCT05415241). It is a single-arm, open-label, multi-dose exploratory clinical study with an enrolment of ~60 subjects who are close contacts of ...
-
Linear Health Sciences Announces Issuance of First US Patent
OKLAHOMA CITY – Linear Health Sciences today announced that the United States Patent and Trademark Office has issued the company’s first patent related to its flagship product, the Orchid Safety Release Valve™. US Patent No. 9,861,805 B2 covers wide-ranging claims behind the needless connector for use in medical access devices such as IV catheters. “The patent issuance ...
-
Multidrug-resistant bacteria remain a public health issue in Europe
On the occasion of the European Antibiotic Awareness Day, ECDC is releasing new European-wide surveillance data on antibiotic resistance from the European Antimicrobial Resistance Surveillance Network (EARS-Net). With annually up to 400,000 patients reported to suffer from infections resistant to multiple antibiotics, the data show that antibiotic resistance remains a public health problem across ...
-
OpGen Announces Publication of Results from Major Clinical Study Using Unyvero Hospitalized Pneumonia (HPN) Panel in the Lancet Respiratory Medicine
208 patients enrolled in a prospective, randomized, controlled, multicenter, interventional trial Unyvero reduced the use of inappropriate antibiotic therapy by 45%, shortened inappropriate antibiotic therapy by 39 hours, and reduced overall antibiotic therapy duration by 22.5% Unyvero results combined with antibiotic stewardship are efficient and safe in decreasing time on inappropriate ...
By OpGen, Inc.
-
C. diff Infections are a Real Concern in Chicago & across Illinois
The environmental and infection control experts at EC2 provide prevention services, inspections and solutions for healthcare facilities battling C. diff threats. Just last week it was reported that an outbreak of C. difficile (C. diff) at a Canadian hospital has already infected 63 patients. The outbreak has caused at least one confirmed death and possibly six others. This latest ...
-
Qualigen Therapeutics, Inc. Announces Submission of Investigational New Drug (IND) Application for QN-165, for the Treatment of COVID-19
Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announced today the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for Qualigen's QN-165 with an initial target indication for the treatment of COVID-19 in hospitalized patients. ...
-
Daxor Announces Key Milestones Achieved for Multicenter BVA-100 Study in Hospitalized Patients With COVID-19
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces patient enrollment is complete and data analysis is underway in preparation for publication of the multi-center observational prospective study utilizing Daxor’s BVA-100 (Blood Volume Analyzer, “BVA”) technology in hospitalized COVID-19 patients. NYU Langone Health, Wake ...
-
Candidiasis Infections Impact Midwest Healthcare Facilities
Candidiasis is caused by fungal pathogens from the Candida genus. Most infections are caused by Candida albicans, a type of fungus that grows both as a yeast and filamentous cells. The ubiquitous fungi represent one of the most common fungal pathogens to affect the human population. According to the Centers for Disease Control and Prevention (CDC), “Invasive candidiasis is a fungal ...
-
Biorez Appoints Jeff Grebner as Director of Clinical Affairs
Biorez Inc., a New Haven, late-stage start-up advancing tendon and ligament healing, today announced the appointment of Jeff Grebner as Director of Clinical Affairs. Grebner joins the Biorez team at an opportune time as the company hits key clinical and procedural milestones with its proprietary BioBrace Implant technology in 2021. “Jeff is a thoughtful clinical leader with ...
By Biorez Inc.
-
Daxor Announces Key Milestones Achieved for Multicenter Bva-100® Study In Hospitalized Patients With Covid-19
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces patient enrollment is complete and data analysis is underway in preparation for publication of the multi-center observational prospective study utilizing Daxor’s BVA-100 (Blood Volume Analyzer, “BVA”) technology in hospitalized COVID-19 patients. NYU Langone Health, Wake ...
-
Delaware IAQ Professional Identifies Fungal Pathogens
Fungal pathogens can be found across the United States and the Mid-Atlantic region is no exception. These fungi cause disease in humans and one of the most recognized types of fungi that cause opportunistic infections in immunocomprimised individuals is known as Candida. Candidiasis is caused by fungal pathogens from the Candida genus. Most infections are caused by Candida albicans, a type ...
-
Infection Control Resources to Safeguard Patients and Building Occupants from Acinetobacter and Other Pathogens
The Centers for Disease Control and Prevention describe Acinetobacter as a group of bacteria commonly found in the environment in places like soil and water. While there are many types, the most frequent cause of infections in humans is known as Acinetobacter baumannii. Those most at risk of infection according to the CDC include patients in hospitals, especially those who: · are ...
-
Vancomycin-Resistant Enterococci (VRE) in Healthcare Settings Discussed in New Online Video
The IAQ Video Network and Cochrane & Associates announced the release of their latest educational video today. Their newest production discusses vancomycin-resistant enterococci, commonly referred to as VRE, which are bacteria that can cause various healthcare-associated infections (HAIs). “In the CDC’s 2019 Antibiotic Resistance Threats in the United States report, VRE was ...
-
UVD Robots Deploys Robot #200 donated by The European Commission to European hospitals
In the last couple of years, the corona virus has caused a huge impact all across Europe. UVD Robots and Blue Ocean Robotics - the manufacturer of the autonomous disinfecting robot equipped with UV-C light - was selected by the European Commission, as a supplier for its autonomous disinfection robots to European Union hospitals in the fight against SARS-CoV-2 known as Coronavirus. Each year ...
-
Patient Satisfaction in Healthcare and the Role of Hand Hygiene Monitoring
Patient satisfaction is critical to the success of hospitals and other healthcare settings. Providers that consistently fail to meet patients’ satisfaction risk damaging their reputation in the community, and patient satisfaction tied to valid health and safety concerns — such as staff not following hand hygiene best practices — can lead to costly healthcare-associated ...
By BioVigil
-
Illinois Same-Day Surgery Centers under the Spotlight
Earlier this month, the Northwest Herald reported about the state of infection control at same-day surgical centers across Illinois. According to the article, of the surgery centers inspected in the past year, 2/3 had been cited for infection control problems. News of these infection control problems coincide with a new federal report that was just released that shows an increase in ...
-
AIDOC and IMBIO partner to provide an industry first ai solution to prioritize suspected pulmonary embolism and automatically calculate RV/LV ratio
Aidoc, the leading provider of enterprise AI solutions, and Imbio, a leading provider of medical image analysis for pulmonary and cardiothoracic diseases, announced today a partnership intended to provide the world’s first end-to-end AI solution for pulmonary embolism (PE), with the goal of ultimately improving efficiency and quality of pulmonary embolism detection and treatment. ...
By Aidoc
-
Showcase
Zeneo® Adrenaline: A New Innovative Formulation
Anaphylactic shock is an absolute medical emergency. When anaphylactic shock is suspected, emergency services must be called and emergency first aid administered immediately. The only first-line treatment for anaphylactic shock is injectable adrenaline1. In the USA: 1.6% to 5.1% of the population has experienced anaphylactic shock, 1% of hospitalizations are caused by it, 0.1% of patients ...
By Crossject
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you